Format

Send to

Choose Destination
Science. 1998 Jan 2;279(5347):98-102.

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.

Author information

1
Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.

Abstract

The preferred antitubercular drug isoniazid specifically targets a long-chain enoyl-acyl carrier protein reductase (InhA), an enzyme essential for mycolic acid biosynthesis in Mycobacterium tuberculosis. Despite the widespread use of this drug for more than 40 years, its precise mode of action has remained obscure. Data from x-ray crystallography and mass spectrometry reveal that the mechanism of isoniazid action against InhA is covalent attachment of the activated form of the drug to the nicotinamide ring of nicotinamide adenine dinucleotide bound within the active site of InhA.

PMID:
9417034
DOI:
10.1126/science.279.5347.98
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center